At the end of Q3 2024, shares of Tilray Brands, Inc. (NASDAQ:TLRY) were held by 16 hedge funds in the IM database with a total stake value of $20.62 million, up 36% from the previous quarter.

Tilray cultivates a wide range of strains to meet patient needs including indicas, sativas, hybrids, and CBD-rich varieties. Medical cannabis is available in two primary forms: extracts and dried ...

Medical announced the expansion of its medical cannabis extract portfolio in Germany. Tilray’s new medical cannabis offerings in ...

Tilray Brands Inc.’s stock fell Friday after the beer and cannabis company said it expects a $20 million impact on its full-year revenue as it embarks on a cost-cutting plan that will reduce the ...